21st International Conference on Alzheimers disease and Dementia

The 21st International Conference on Alzheimers disease and Dementia explores innovative approaches and solutions in Alzheimer`s disease research, early diagnosis, therapeutic interventions, and support systems for affected individuals and caregivers.

Key Topics

• Artificial Intelligence and Machine Learning in Alzheimer’s Care
• The Gut-Brain Axis: A New Frontier in Alzheimer’s Research
• Genetics and Epigenetics: Understanding Alzheimer’s Risk
• Targeting Amyloid and Tau: Current and Emerging Therapies
• Sex Differences in Alzheimer’s Disease: Understanding the Gender Gap
• Neuroinflammation: The Silent Driver of Alzheimer’s Pathology
• Non-Pharmacological Interventions in Dementia Care: Beyond Medications
• Advanced Drug Delivery Systems: Crossing the Blood-Brain Barrier
• Alzheimer’s Disease in Low- and Middle-Income Countries: Overcoming Global Challenges
• Innovations in Clinical Trials: Accelerating Alzheimer’s Research
• Cognitive Rehabilitation and Enhancing Neuroplasticity
• Caregiver Burden and Support: Strategies for Resilience and Coping
• Personalized Medicine in Alzheimer’s Disease: Tailoring Treatment to Individuals
• Lifestyle Interventions: Prevention through Diet, Exercise, and Social Engagement
• Early Diagnosis and Biomarkers: Shaping the Future of Detection

Who should Attend

• Neuroscientists and Neurologists
• Pharmaceutical Researchers and Biotechnologists
• Clinical Trial Coordinators and Data Analysts
• Healthcare Policy Makers
• Gerontologists and Psychologists
• Alzheimer’s Disease and Dementia Care Professionals
• Academics and Graduate Students in Medical Research
• Cognitive Rehabilitation Specialists
• Caregivers and Social Workers
• Technology and AI Developers in Healthcare
• Public Health and Global Health Experts